What's breaking now, across thousands of outlets.
The Phase 3 findings suggested Kodiak might have multiple threats to Regeneron’s Eylea and added more than $3 billion to the company’s market value.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
Several significant pledges for global health – covering reproductive health, ‘transition’ and Ebola – were made on the fringes of last week’s United Nations General Assembly amid massive donor…
By mapping brain activity like a moving weather system, researchers found that psychedelics consistently reduce the upward flow of sensory information into higher-order brain regions, offering new…
When our second child was born, my spouse had several weeks of paternity leave under his parental leave policy at work.
Having cancer was unequivocally not a good thing, but there were good things about it. I can understand why people might want those things.
